Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

HIV and hepatitis virus resistance to antivirals: review of data from the XIX International HIV and Hepatitis Virus Drug Resistance Workshop and curative strategies.

Mascolini M, Mellors JW, Richman DD, Boucher CA, Larder BA.

Antivir Ther. 2011;16(2):263-86. doi: 10.3851/IMP1761.

PMID:
21447877
2.

Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.

Buti M.

IDrugs. 2008 Apr;11(4):239-41. No abstract available.

PMID:
18379952
3.

Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop.

Mascolini M, Boucher CA, Mellors JW, Larder BA, Richman DD.

Antivir Ther. 2009;14(7):1015-37. doi: 10.3851/IMP1423.

PMID:
19918107
4.

Clinical implications of resistance to antiretrovirals: new resistance technologies and interpretations.

Mascolini M, Richman D, Larder B, Mellors J, Boucher CA.

Antivir Ther. 2008;13(2):319-34.

PMID:
18505183
5.

Antiviral research--21st international conference.

Turner B.

IDrugs. 2008 Jun;11(6):401-4. No abstract available.

PMID:
18509777
6.

Primary infection with a lamivudine-resistant hepatitis B virus.

Thibault V, Aubron-Olivier C, Agut H, Katlama C.

AIDS. 2002 Jan 4;16(1):131-3. No abstract available.

PMID:
11741175
8.

[Mechanisms of drug resistance in hepatitis viruses B and C].

Yotsuyanagi H, Koike K.

Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:493-6. Review. Japanese. No abstract available.

PMID:
17455669
9.

Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV-HCV-coinfected patients.

Treviño A, de Mendoza C, Parra P, Rodríguez C, Madejón A, Plaza Z, del Romero J, Poveda E, Soriano V.

Antivir Ther. 2011;16(3):413-6. doi: 10.3851/IMP1760.

PMID:
21555824
10.

Designing a low-cost drug resistance database for viral hepatitis.

Kuiken C.

Antivir Ther. 2010;15(3 Pt B):517-20. doi: 10.3851/IMP1554. Review.

PMID:
20516573
11.

The implications of antiviral drugs with activity against hepatitis B virus and HIV.

Bottecchia M, Garcia-Samaniego J, Soriano V.

Curr Opin Infect Dis. 2007 Dec;20(6):621-8. Review.

PMID:
17975413
12.

Surveillance of HIV and viral hepatitis by analysis of samples from drug related deaths.

Christensen PB, Kringsholm B, Banner J, Thomsen JL, Cowan S, Stein GF, Jürgensen GW, Grasaasen K, Georgsen J, Pedersen C.

Eur J Epidemiol. 2006;21(5):383-7.

PMID:
16763882
13.

[Hepatitis B and C virus antiviral resistance].

Sáez-López A, Agüero-Balbín J.

Enferm Infecc Microbiol Clin. 2006 Nov;24(9):576-84. Review. Spanish.

PMID:
17125678
14.

Drug-resistant viral hepatitis.

Wright M, Main J, Thomas HC.

J Infect. 2000 Jul;41(1):1-4. Review. No abstract available.

PMID:
10942634
15.
16.

Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.

Menzo S, Vincenti D, Solmone M, Prosperi M, Bruselles A, Abbate I, Rozera G, Capobianchi MR.

J Infect Dis. 2009 Dec 1;200(11):1798-9; author reply 1799-1800. doi: 10.1086/647991. No abstract available.

PMID:
19905934
17.

Virology of hepatitis B and C viruses and antiviral targets.

Pawlotsky JM.

J Hepatol. 2006;44(1 Suppl):S10-3. Review.

PMID:
16338022
18.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
19.

Broad advances in understanding HIV resistance to antiretrovirals: report on the XVII International HIV Drug Resistance Workshop.

Mascolini M, Larder BA, Boucher CA, Richman DD, Mellors JW.

Antivir Ther. 2008;13(8):1097-113.

PMID:
19195337
20.

Key reports from the XV International HIV Drug Resistance Workshop 2006.

Mascolini M, Boucher C, Larder B, Mellors J, Richman D.

Antivir Ther. 2007;12(1):131-45.

PMID:
17503758
Items per page

Supplemental Content

Support Center